TY - JOUR
T1 - Phosphoproteomic Landscaping Identifies Non-canonical cKIT Signaling in Polycythemia Vera Erythroid Progenitors
AU - Federici, Giulia
AU - Varricchio, Lilian
AU - Martelli, Fabrizio
AU - Falchi, Mario
AU - Picconi, Orietta
AU - Francescangeli, Federica
AU - Contavalli, Paola
AU - Girelli, Gabriella
AU - Tafuri, Agostino
AU - Petricoin, Emanuel F.
AU - Mazzarini, Maria
AU - Zeuner, Ann
AU - Migliaccio, Anna Rita
N1 - Publisher Copyright:
© Copyright © 2019 Federici, Varricchio, Martelli, Falchi, Picconi, Francescangeli, Contavalli, Girelli, Tafuri, Petricoin, Mazzarini, Zeuner and Migliaccio.
PY - 2019/11/22
Y1 - 2019/11/22
N2 - Although stem cell factor (SCF)/cKIT interaction plays key functions in erythropoiesis, cKIT signaling in human erythroid cells is still poorly defined. To provide new insights into cKIT-mediated erythroid expansion in development and disease, we performed phosphoproteomic profiling of primary erythroid progenitors from adult blood (AB), cord blood (CB), and Polycythemia Vera (PV) at steady-state and upon SCF stimulation. While AB and CB, respectively, activated transient or sustained canonical cKIT-signaling, PV showed a non-canonical signaling including increased mTOR and ERK1 and decreased DEPTOR. Accordingly, screening of FDA-approved compounds showed increased PV sensitivity to JAK, cKIT, and MEK inhibitors. Moreover, differently from AB and CB, in PV the mature 145kDa-cKIT constitutively associated with the tetraspanin CD63 and was not endocytosed upon SCF stimulation, contributing to unrestrained cKIT signaling. These results identify a clinically exploitable variegation of cKIT signaling/metabolism that may contribute to the great erythroid output occurring during development and in PV.
AB - Although stem cell factor (SCF)/cKIT interaction plays key functions in erythropoiesis, cKIT signaling in human erythroid cells is still poorly defined. To provide new insights into cKIT-mediated erythroid expansion in development and disease, we performed phosphoproteomic profiling of primary erythroid progenitors from adult blood (AB), cord blood (CB), and Polycythemia Vera (PV) at steady-state and upon SCF stimulation. While AB and CB, respectively, activated transient or sustained canonical cKIT-signaling, PV showed a non-canonical signaling including increased mTOR and ERK1 and decreased DEPTOR. Accordingly, screening of FDA-approved compounds showed increased PV sensitivity to JAK, cKIT, and MEK inhibitors. Moreover, differently from AB and CB, in PV the mature 145kDa-cKIT constitutively associated with the tetraspanin CD63 and was not endocytosed upon SCF stimulation, contributing to unrestrained cKIT signaling. These results identify a clinically exploitable variegation of cKIT signaling/metabolism that may contribute to the great erythroid output occurring during development and in PV.
KW - cKIT
KW - erythroid progenitors
KW - erythropoiesis
KW - polycythemia vera
KW - stem cell factor
UR - http://www.scopus.com/inward/record.url?scp=85077026924&partnerID=8YFLogxK
U2 - 10.3389/fonc.2019.01245
DO - 10.3389/fonc.2019.01245
M3 - Article
AN - SCOPUS:85077026924
SN - 2234-943X
VL - 9
JO - Frontiers in Oncology
JF - Frontiers in Oncology
M1 - 1245
ER -